National Health (Pharmaceutical Benefits) Regulations (Amendment)

Administered by Department of Health, Disability and Ageing

Legislation au F1996B02859 Regulations Not in force Legislative Instrument

Legislation content

STATUTORY RULES

1965 No. 151

__________

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1964.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1964.

Dated this twenty-first

day of October, 1965.

CASEY

Governor-General.

By His Excellency’s Command,

(Signed) Ian Sinclair

Minister of State for Social Services

acting for and on behalf of the

Minister of State for Health.

________

Amendments of the National Health (Pharmaceutical Benefits) Regulations

Commencement.

1. These Regulations shall come into operation on the first day of November, 1965.

First Schedule.

2. The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting the word—

“Calciferol.”;

(b) by omitting the words—

“Chlorcyclizine Hydrochloride.”;

(c) by omitting the word—

“Hydrochlorothiazide.”;

(d) by omitting the words—

“Mustine Hydrochloride.”;

(e) by inserting after the words—

“Nitrous Oxide.”

the words—

“Norethandrolone.

Norethandrolone Tablets.”;

(f) by inserting after the word—

“Noscapine.”

the words—

“Novobiocin Calcium.

Novobiocin Sodium.”;

 

*Notified in the Commonwealth Gazette on 28 October, 1965.

† Statutory Rules 1960, No. 17, as amended to date. For previous amendments of the National Health (Pharmaceutical Benefits) Regulations, see footnote † to Statutory Rules 1965, No. 51 and see also Statutory Rules 1965, No. 51.

11409/65.—Price 2s. 6d. (25c)  10/5.10.1965


(g) by omitting the words—

“Piperazine Phosphate”; and

(h) by inserting after the words—

“Undecenoic Acid.”

the words—

“Vancomycin Hydrochloride.

Vancomycin Injection.”.

3. The Second Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

Second Schedule.

(a) by omitting the item relating to the pharmaceutical benefit

“Adrenaline Acid Tartrate, B.P.”;

(b) by omitting the item relating to the pharmaceutical benefit

“Aluminium Hydroxide Gel Dried, B.P.”;

(c) by inserting after the item relating to the pharmaceutical benefit

“Betamethasone Phosphate” the following item:—

“ Calciferol........................

—”;

(d) by inserting after the item relating to the pharmaceutical benefit

“Erythromycin Oral Suspensions” the following item:—

“Erythromycin Paediatric Drops..........

—”;

(e) by omitting the item relating to the pharmaceutical benefit

“Ferrous Gluconate, B.P.”;

(f) by inserting after the item relating to the pharmaceutical benefit

“Framycetin Sulphate” the following item:—

“Fusidic Acid (Diethanolamine Salt).......

—”;

(g) by omitting the item relating to the pharmaceutical benefit

“Magnesium Bicarbonate Solution, B.P. 1948”;

(h) by inserting after the item relating to the pharmaceutical benefit

“Mepyramine Maleate, B.P.” the following item:—

“Methacycline......................

—”;

(i) by omitting the item relating to the pharmaceutical benefit

“Paracetamol, B.P.”;

(j) by omitting the item relating to the pharmaceutical benefit

“Sulphadimethoxine, B.P.C.”;

(k) by omitting the item relating to the pharmaceutical benefit

“Sulphamethoxydiazine”;

(l) by omitting the item relating to the pharmaceutical benefit

“Sulphamethoxypyridazine N-Acetyl”; and

(m) by inserting after the item Telating to the pharmaceutical benefit

“Surgical Cement” the following item:—

“Surgical Cement Solvent..............

—”.


Third and Fifth Schedules.

4. The Third and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

THIRD SCHEDULE

Regulation 11

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia

Acetazolamide Sodium.

Acetohexamide.

Acidified Golden Syrup, A.P.F. 1955.

Acriflavine, B.P.C.

Acrylic Resin.

Adrenaline Hydrochloride.

Adrenaline Mucate.

Agar B.P.C. 1954.

Alkavervir.

Aloin B.P.C.

Almond Oil Volatile Bitter, B.P.C. 1959.

Aloxidone.

Aluminium Acetate Solution, B.P.C.

Aluminium Hydroxide Mixture, A.P.F.

Aluminium Hydroxide Mixture, A.P.F. 1955.

Aluminium Sodium Polyhydroxy Mon-ocarbonate Hexitol

   Complex.

Aluminium Sodium Silicate.

Aluminium Powder, B.P.C.

Amaranth Solution, A.P.F.

Amaranth Solution, Compound, A.P.F.

Amaranth Solution, B.P.C.

Aminocaproic Acid.

Amitriptyline Hydrochloride.

Ammonia Aromatic Spirit, B.P.C.

Ammonia Solution Strong, B.P.C.

Ammonium Bicarbonate, B.P.C.

Ammonium Bromide, B.P.C.

Amphotericin B.

Ampicillin.

Antazoline Methanesulphonatc, B.P.C.

Antazoline Sulphate.

Attapulgite.

Aurothioglucose.

Azathioprine.

Beclamide.

Beeswax, Yellow, B.P.C.

Belladonna Suppository, B.P. 1948.

Benedict’s Solution, A.P.F.

Benzalkonium Chloride.

Benzoin, B.P.C.

Benzoinated Lard, B.P.C. 1954.

Benzoin Compound Tincture, B.P.C.

Benzoin Tincture, B.P.C.

Benzylpenicillin in Oil.

Bephenium Hydroxynaphthoate, B.P.C.

Betamethasone.

Betamethasone Disodium Phosphate.

Betamethasone Phosphate.

Bethanidine Sulphate.

Bismuth Subgallate, B.P.C.

Bretylium Tosylate.

Brown Snake Antivenene.

Buchu Concentrated Infusion, B.P.C. 1954.

Butabarbital Sodium.

Butyl Aminobenzoate, B.P. 1953.

Cade Oil, B.P.C.

Caffeine and Sodium Benzoate, B.P.C. 1954.

Caffeine Citrate, B.P.C. 1959.

Cajuput Spirit, B.P. 1948.

Calamine Cream, A.P.F. 1955.

Calcium Aurothiomalate.

Calcium Di-Oxytetracycline.

Calcium Gluconogalactogluconate.

Calcium Lactobionate.

Calcium Phosphate, B.P.C.

Calumba, Concentrated Infusion, B.P. 1948.

Calumba Tincture, B.P. 1948.

Capsicum Ointment, B.P.C.

Capsicum Tincture, B.P.C.

Carbamazepine.

Carbarsone, B.P.C.

Carbinoxamine Maleate.

Cardamom Aromatic Tincture, B.P.C.

Catechu Tincture, B.P.C.

Cetomacrogol Emulsifying Wax, B.P.C.

Cetyl Alcohol Compound.

Chloramine, B.P.C.

Chloramphenicol Palmitate, B.P.C.

Chloramphenicol Stearate.

Chloramphenicol Succinate.

Chlorazanil Hydrochloride.

Chlorhexidine Diacetate.

Chlorhexidine Gluconate.

Chlorobenzol Disulphonamide.

Chlorotrianisene, B.P.C.

Chlorthalidone, B.P.C.

Choline Theophyllinate, B.P.C.

Cinnamon Spirit, B.P.C. 1949.

Cinnamon Water, Concentrated, B.P.C.

Clemizole Hydrochloride.

Clemizole Tannate.

Clopamide.

Clove, Concentrated Infusion, B.P.C. 1954.

Cloxacillin Sodium.

Coal Tar, B.P.C.

Cochineal Tincture, B.P. 1948.

Coconut Oil, B.P.C. 1949.

Codeine, B.P.C. 1954.

Copper Sulphate, B.P.C.

Creosote, B.P.C. 1959.

Cudbear Tincture, A.P.F. 1947.

Curd Soap, B.P.C.

Cyclopenthiazide.

Cyclophosphamide.

Cyclothiazide.

Cycrimine Hydrochloride.

Cymogran.

Cyproheptadine Hydrochloride.

Death Adder Antivenene.


Third Schedulecontinued

Demecarium Bromide.

Deoxycortone Glucoside.

Desferrioxamine.

Deslanoside.

Dexamethasone Sodium Phosphate.

Dexchlorpheniramine Maleate.

Dextran.

Dextriferron.

Dicyclomine Hydrochloride, B.P.C.

Digitalis Tincture, B.P.C. 1959.

Dihydroergotamine Methanesulphonate.

Dihydromorphinone Hydrochloride, B.P.C. 1949.

Dihydrostreptomycin Sulphate, B.P. 1958.

Dihydrotachysterol.

Dimethicone, B.P.C.

Diphenylpyraline Hydrochloride.

Dipyridamole.

Disodium Stilboestrol Diphosphate.

Dithiazanine Iodide.

Dyflos, B.P.C.

Ecothiopate Iodide.

Entsufon.

Ephedrine, B.P.C.

Ergot, Liquid Extract, B.P. 1914.

Erythromycin Ethyl Succinate.

Erythromycin Glucoheptonate.

Erythromycin Lactobionate.

Erythromycin Stearate.

Ethanolamine, B.P.C.

Ethanolamine Oleate.

Ether Nitrous Spirit, B.P.C. 1959.

Ethionamide.

Ethosuximide.

Ethoxzolamide.

Ethyl Biscoumacetate, B.P.C.

Ethylidene Dicoumarin.

Ethylnoradrenaline Hydrochloride.

Ethyloestrenol.

Eucalyptol, B.P.C.

Extract of Ox Bile, B.P. 1948.

Ferric Hydroxide.

Ferrous Aminoacetosulphate.

Ferrous Carbonate Saccharated, B.P.C. 1959.

Ferrous Phosphate Compound Syrup, B.P.C.

Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.

Ferrous Succinate.

Folinic Acid.

Framycetin Sulphate.

Frusemide.

Fusidic Acid, Diethanolamine Salt.

Fusidic Acid, Sodium Salt.

Galactomin.

Gall and Opium Ointment, B.P.C.

Gelsemium Tincture, B.P.C.

Glucagon Hydrochloride.

Glucose Indicator.

Glycerophosphate Compound Syrup, A.P.F.

Glycopyrronium Bromide.

Goats Milk, dehydrated.

Gramicidin.

 

Hamamelis Dry Extract, B.P.C.

Hamamelis Liquid Extract, B.P.C.

Heparin Retard.

Hexocyclium Methylsulphate.

Honey, Purified, B.P.C.

Hydrargaphen.

Hydrocyanic Acid, Dilute, B.P.C. 1954.

Hydroxybenzoate Compound Powder, A.P.F.

Hydroxyprogesterone Caproate.

Hyoscine Methobromide.

Hypophosphorous Acid, Dilute, B.P.C.

Idoxuridine.

Indomethacin.

Insulin Injection, specially purified.

Insulin Isophane Injection, specially purified.

Insulin Injection, Special P (Pig).

Iodochlorhydroxyquinoline.

Iodoform, B.P.C. 1954.

Iron Aminoates.

Iron Dextran.

Iron Oxide Saccharated.

Iron Sorbitol Complex.

Isoprenaline Hydrochloride.

Isopropamide Iodide.

Isothipendyl Hydrochloride, B.P.C.

Kanamycin Sulphate, B.P.C.

Kitasamycin.

Lanatoside-C.

Lavender Spike Oil, B.P.C.

Lemon Tincture, B.P. 1958.

Lipopancreatin.

Lissapol.

Lobelia Ethereal Tincture, B.P.C.

Lofenalac.

Lypressin.

Magenta, B.P.C.

Magnesium Chloride.

Magnesium Hydroxide, B.P.C.

Mebhydrolin Napadisylate, B.P.C.

Medroxyprogesterone Acetate.

Mercaptomerin Sodium.

Mestanolone.

Metaraminol Bitartrate.

Metformin Hydrochloride.

Methacycline.

Methazolamide.

Methdilazine Hydrochloride.

Methenamine Mandelate.

Methenolone Acetate.

Methotrexate.

Methoxamine Hydrochloride, B.P.C.

Methsuximide.

Methyclothiazide.

Methyldopa.

Methyl Glucamine.

Methylphenobarbitone, B.P.C.

Methylprednisolone Acetate.

Metronidazole, B.P.C.

Minafen.

Morphine Tartrate.

Myrrh Gum, Powdered, B.P.C.

Myrrh Tincture, B.P.C.

Nalidixic Acid.

 


Third Schedulecontinued

Nandrolone Decanoate.

Niclosamide.

Nicotinyl Alcohol Tartrate.

Nicoumalone.

Nitromin.

Nux Vomica, Dry Extract, B.P.C.

Oestradiol Dipropionate, B.P.C. 1954.

Oestrone, B.P.C. 1954.

Oily Ophthalmic Vehicle, A.P.F. 1955.

Orange Peel Compound, Concentrated Infusion, B.P.C. 1954.

Orange Peel, Concentrated Infusion, B.P.C.

Orciprenaline Sulphate.

Oxycodone Pectinate.

Oxymel, B.P.C.

Oxymel of Squill, B.P.C.

Oxymesterone.

Oxyphencyclimine Hydrochloride.

Oxyphenonium Bromide.

Oxytocin.

Pancreatin Enzyme, U.S.N.F. XI.

Papaveretum, B.P.C.

Para-Aminosalicylic Acid.

Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955.

Paraben Ophthalmic Vehicle, A.P.F. 1955.

Paraffin Liquid Light, B.P.C.

Paramethasone Acetate.

Pargyline Hydrochloride.

Pectin.

d-Penicillamine Hydrochloride, B.P.C.

Penicillinase.

Penicillin, Benethamine, B.P.C.

Pentaerythritol Tetranitrate, diluted, B.P.C.

Penthienate Methobromide.

Pertussis Vaccine (Haemagglutinin Aluminium

   Phosphate Adsorbed).

Peru Balsam, B.P.C.

Phenazone, B.P.C.

Phenazopyridine Hydrochloride.

Phenethicillin Potassium.

Phenformin Hydrochloride.

Pheniramine Maleate.

Pheniramine Para-Aminosalicylate.

Phenol Ointment, B.P. 1948.

Phenoxymethylpenicillin, Benzathine.

Phenoxymethylpenicillin, Hydrabamine.

Phensuximide.

Phenytoin.

Phthalylsulphacetamide.

Physostigmine, B.P.C.

Pipenzolate Methobromide.

Pituitary (Posterior Lobe) Powdered, B.P.C.

Polythiazide.

Potable Water.

Potassium Chlorate, B.P.C.

Potassium, Effervescent Tablets.

Prednisolone Sodium Hemisuccinate.

Prednisolone Sodium Hemisulphate.

Prednisolone Sodium Phosphate, B.P.C.

Prednisolone Tertiary Butyl Acetate.

Protoveratrine A.

Pumilio Pine Oil, B.P.C.

Pyrazinamide.

Pyridine Aldoxime Methiodide.

Quillaia Tincture, B.P.C.

Quinethazone.

Raspberry Syrup, B.P.C.

Rauwolfia Alkaloids.

Red Back Spider Antivenene.

Rolitetracycline.

Rosemary Oil, B.P.C.

Salicylamide.

Senega, Concentrated Infusion, B.P.C.

Senna Compound Mixture, B.P.C. 1959.

Senna, Concentrated Infusion, B.P.C. 1959.

Senna Fruit Extract (Standardised).

Siberian Fir Oil, B.P.C. 1949.

Silver Protein, B.P.C.

Silver Protein Mild, B.P.C.

Sobee.

Sodium Carbonate Anhydrous, B.P.C.

Sodium Edetate, B.P.C.

Sodium Folate.

Sodium Lactate.

Sodium Nitrite, B.P.C.

Sodium Potassium Tartrate, B.P.C.

Sodium Tauroglycocholate, B.P.C. 1954.

Spearmint Oil, B.P.C.

Spiramycin.

Spironolactone, B.P.C.

Squill Tincture, B.P.C.

Stanolone.

Stanozolol.

Stearic Acid, B.P.C.

Storax, Prepared, B.P.C.

Strophanthus Tincture, B.P. 1948.

Strychnine, B.P.C. 1959.

Sulphacetamide, B.P.C.

Sulphadiazine Sodium, B.P.C.

Sulphadimethoxine, B.P.C.

Sulphaguanidine, B.P.C.

Sulphamerazine, B.P. 1958.

Sulphamethoxydiazine.

Sulphaphenazole, B.P.C.

Sulphapyridine, B.P.C. 1959.

Sulphasalazine.

Sulphathiazole, B.P.C.

Sulphinpyrazone, B.P.C.

Sulphurated Potash, B.P.C.

Sulphuric Acid, Dilute, B.P.C.

Sulphur Sublimed, B.P.C.

Sultiame.

Surgical Cement.

Surgical Cement Solvent.

Sustanon.

Syrup Glucose Liquid, B.P.C.

Tacrine.

Taipan Antivenene.

Tar Ointment, B.P.C. 1959.

Tartrazine, B.P.C. 1954.

Testosterone Oenanthate.

Tetanus Immune Globulin (Human).

Tetracycline.

Thenalidine.

Thenalidine Tartrate.

Theobromine, B.P.C.

 


Third Schedulecontinued

Theobromine and Sodium Salicylate, B.P. 1953.

Theophylline Ethanoate of Piperazine.

Thiethylperazine.

Thioridazine.

Thiotepa.

Thyrotrophin.

Tiger Snake Antivenene.

Titanium Dioxide, B.P.C.

Tolu Tincture, B.P.C. 1959.

Tragacanth (Gum Karaya).

Tretamine.

Triamcinolone, B.P.C.

Triamterene.

Tricyclamol Chloride.

Tridihexethyl Chloride.

Triethanolamine, B.P.C

Trimeprazine Tartrate, B.P.C.

Trimustine Hydrochloride.

Trinitrophenol, B.P.C. 1959.

Triprolidine Hydrochloride, B.P.C.

Trolnitrate Phosphate.

Vadrine.

Valerian Ammoniated Tincture, B.P.C.

Vanillin.

Vasopressin Tannate.

Velactin.

Vinblastine Sulphate.

Vincristine Sulphate.

Vinegar of Squill, B.P.C.

Viomycin Pantothenate.

Viprynium Embonate.

Vitamin A.

Vitamin D.

 

________________

FIFTH SCHEDULE

Regulation 14

Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

Acetylsalicylic Acid Tablets, B.P.......

 

Soluble Acetylsalicylic Acid Tablets, B.P.

 

Compound Acetylsalicylic Acid Tablets, A.P.F.

Any disease or condition in a pensioner

Compound Acetylsalicylic Acid Tablets, B.P.C.

 

Soluble Compound Acetylsalicylic Acid Tablets

 

Acrylic Resin...................

Ileostomy or colostomy conditions

Alkavervir.....................

Hypertensive crises

Aminocaproic Acid...............

Any disease or condition in a patient receiving treatment in or at an approved hospital.

Amitriptyline Hydrochloride.........

Any disease or condition in a patient receiving treatment in or at an approved hospital.

 

With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

 

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride


Fifth Schedulecontinued

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

Amphotericin B..............

Systemic fungal infection

Ampicillin Capsules............

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Ampicillin is the only appropriate antibiotic

Ampicillin Injections...........

Any disease or condition in a patient receiving treatment in or at an approved hospital

Ampicillin Tablets.............

Aneurine Hydrochloride Tablets, B.P.

Any disease or condition in a pensioner

Ascorbic Acid Tablets, B.P........

Azathioprine.................

Any disease or condition in a patient receiving treatment in or at an approved hospital

Beclamide..................

Bemegride Injection, B.P.........

As an antidote to barbiturate and other hypnotic poisons

Betamethasone Tablets..........

With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets

Betamethasone Disodium Phos-phate Injection

Intra-articular use

Bethanidine Sulphate...........

Any disease or condition in a patient receiving treatment in or at an approved hospital

Busulphan Tablets, B.P..........

Leukaemia

Calciferol Tablets, B.P...........

Any disease or condition in a pensioner

With the written authority of the Director-General—

Calciferol, B.P................

Hypoparathyroidism

 

Chronic hypoparathyroid tetany

 

Vitamin D-resistant rickets

Calcium Aminosalicylate........

Tuberculosis

Calcium Gluconogalactogluconate Effervescent Tablets

Hypoparathyroidism

Caramiphen Tablets, B.P.........

Parkinsonism

Carbamazepine...............

Epilepsy

 

Trigeminal neuralgia

Chlorambucil Tablets, B.P........

Malignant lymphoma and related conditions

Chloramine Deodorant Tablets and Powder

Ileostomy or colostomy conditions

Chloramphenicol Capsules, B.P....

Bacterial meningitis

 

Haemophilus influenzae infections

 

Intra-ocular infections

 

Rickettsial infections

 

Salmonella septicaemia

 

Typhoid and paratyphoid

 

Other serious infections sensitive only to Chloramphenicol

Chloramphenicol Injections.......

A disease or condition specified in this column in relation to Chloramphenicol Capsules

Chloramphenicol Tablets........

Chloramphenicol Oral Suspension..

Chlorotrianisene Tablets.........

Carcinoma of the prostate

Chlorpromazine Hydrochloride....

Any disease or condition in a pensioner

 

Any disease or condition in a patient receiving treatment in or at an approved hospital

 

With the written authority of the Director-General—

 

Late-stage malignancy

 

Radiation sickness


Fifth Schedulecontinued

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

 

With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

 

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride

Chlortetracycline Capsules, B.P....

Brucellosis

 

Herpes zoster ophthalmicus

 

Intestinal amoebiasis

 

Leptospirosis

 

Lymphogranuloma venereum

 

Psittacosis

 

Rickettsial infections

 

Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins.

 

Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur

Chlortetracycline Hydrochloride Granules

A disease or condition specified in this column in relation to Chlortetracycline Capsules

Choline Theophyllinate..........

Any disease or condition in a patient receiving treatment in or at an approved hospital

Cloxacillin Sodium............

Compound Codeine Tablets, B.P....

 

Compound Codeine Soluble Tablets, B.P.

 

Codeine Phosphate with Acetylsalicylic Acid Soluble Tablets 

 

Codeine Phosphate with Acetylsalicylic Acid Tablets

Any disease or condition in a pensioner

Codeine Phosphate with Acetylsalicylic Acid and Phenacetin Tablets 

 

Codeine Phosphate with Acetylsalicylic Acid, Phenacetin and Caffeine Tablets 

 

Cod Liver Oil Emulsion.........

Any disease or condition in a child under the age of twelve years or in a pensioner

 

With the written authority of the Director-General—

Corticotrophin Injection, B.P......

A disease or condition specified in this column in relation to Cortisone Injection

Corticotrophin Gelatin Injection, B.P.

Hypsarrhythmia

Corticotrophin Zinc Hydroxide Injection, B.P. 

Salaam convulsions

 

The prevention of side effects of corticosteroid therapy

Cortisone Injection, B.P.........

With the written authority of the Director-General—

 

Anaemia, acquired hacmolytic

 

Addison’s disease

 

Adrenocortical hypoplasia

 

Adrenalectomy, total

 

Adrenogenital syndrome


Fifth Schedulecontinued

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

Cortisone Injection, B.P.-continued

Agranulocytosis

 

Behcet’s syndrome

 

Cranial arteritis

 

Cushing’s syndrome, including hyperadrenocorticalism

 

Dematitis, acute exfoliative

 

Dermatomyositis

 

Encephalomyelitis

 

Encephalomyelitis, acute disseminated

 

Guillain-Barré syndrome

 

Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis

 

Hansen’s disease

 

Hepatitis, progressive or continuing, proven by biopsy or biochemistry

 

Hodgkin’s disease

 

Idiopathic hypercalcaemia

 

Inflammatory conditions of the uveal tract and retina

 

Keratoplasty

 

Leucine-sensitive hypoglycaemia

 

Leukaemia

 

Lymphosarcoma and follicular lymphoma

 

Metastatic breast cancer

 

Mycosis fungoidcs

 

Nephrosis or nephrotic syndrome

 

Neuromyelitis optica

 

Optic neuritis following removal of tumor of the brain

 

Panhypopituitarism

 

Pemphigus

 

Periarteritis nodosa

 

Progressive transverse myelitis

 

Pseudohermaphroditism

 

Purpura, Henoch’s

 

Purpura, thrombocytopenic

 

Regional ileitis (Crohn’s disease)

 

Reticulum cell sarcoma

 

Rheumatic carditis, acute

 

Sarcoidosis

 

Scleroderma

 

Severe reactions of the skin and mucosa following X-ray therapy

 

Splenic neutropenia

 

Status asthmaticus

 

Steroid therapy prior to operation in patients under steroid therapy

 

Stevens-Johnson syndrome

 

Still’s disease in a child under the age of sixteen years

 

Sympathetic ophthalmitis

 

Systemic lupus erythematosus

 

Temporal arteritis

 

Tropical and non-tropical sprue and all forms of malabsorption associated with those diseases

 

Type II Nephritis

 

Ulcerative colitis proven by sigmoidoscopy or radiological report

Cortisone Tablets, B.P...........

With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection


Fifth Schedulecontinued

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

Cyanocobalamin Injection, B.P. (other than 1,000 microgram strength)

Established megalocytic anaemia

Cyanocobalamin Injection, B.P. (1,000 microgram strength)

Neuroblastoma

Subacute combined degeneration of the cord

Cymogran..................

With the written authority of the Director-General, phenylketonuria

Cycloserine, B.P...............

Any disease or condition in a patient receiving treatment in or at an approved hospital

Cycloserine Capsules, B.P........

Dapsone Tablets, B.P...........

Hansen’s disease

Demethylchlortetracycline Capsules, B.P.

A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus

Pemethylchlortetracycline Hyd-rochloride Oral Paediatric Drops and Oral Suspension

Deodorant Detergent Solution (Lis-sapol with Spearmint Oil and Cetrimide)

Ileostomy or colostomy conditions

Deoxycortone Aqueous Injections

 

Deoxycortone Acetate Injection, B.P.

 

Deoxycortone Trimethylacetate Injection, B.P.

Addison’s disease Adrenalectomy,

total

Deoxycortone Acetate Implants, B.P.

 

Deoxycortone Acetate Tablets.....

 

Desferrioxamine..............

Any disease or condition in a patient receiving treatment in or at an approved hospital

Dexamethasone Tablets, B.P......

With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets

Dexamethasone Sodium Phosphate Injections

Intra-articular use

Dienoestrol Cream............

Any disease or condition in a pensioner

Dienoestrol Tablets, B.P.........

Carcinoma of the prostate

 

Mammary carcinoma

 

Any disease or condition in a pensioner

Dihydrostreptomycin Sulphate Injection

As an alternative to Streptomycin Sulphate in the case of a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate

Dihydrotachysterol............

Parathyroid deficiency

Diiodohydroxyquinoline Vaginal Tablet

Trichomonal or monilial vaginitis

Diiodohydroxyquinoline Effervescent Gynaecological Pessary

Diloxanide Furoate Tablets, B.P....

Amoebic dysentery

Dimethicone................

Ileostomy or colostomy conditions

Disodium Stilboestrol Diphosphate

Carcinoma of the prostate

Dithiazanine Iodide............

Infestations of Trichuris trichiura or Strongyloides stercoralis

Ditophal...................

Any disease or condition in a patient receiving treatment in or at an approved hospital

Erythromycin................

Staphylococcal septicaemia or pneumonia

 

Any gram-positive bacterial infections where these cannot be treated safely and effectively by sulphonamides or penicillins

Ethinyloestradiol Tablets, B.P......

Turner’s syndrome

 

Pre-menopausal castration syndrome

 

Any disease or condition in a pensioner

Ethionamide.................

Tuberculosis


Fifth Schedulecontinued

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

Ethisterone Tablets, B.P.........

Turner’s syndrome

Ethyloestrenol...............

With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis

Fludrocortisone Tablets, B.P......

Addison’s disease

 

Adrenocortical hypoplasia

Fluoxymesterone Tablets, B.P.....

Castration syndrome (male and female)

 

Mammary carcinoma

 

With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis

Folic Acid Injection............

Macrocytic anaemia

Folic Acid Tablets, B.P..........

Sprue or the sprue-like syndrome

Folinic Acid.................

Any disease or condition in a patient receiving treatment in or at an approved hospital

Framycetin Sulphate Tablets......

Bowel sterilization preparatory to major surgery.

Fusidic Acid (Sodium Salt or Diethanolamine Salt) 

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Fusidic Acid (Sodium Salt or Diethanolamine Salt) is the only appropriate antibiotic.

Galactomin.................

With the written authority of the Director-General, galactosaemia

Goats Milk, dehydrated.........

With the written authority of the Director-General, cows milk allergy in children under the age of four years

Griseofulvin Tablets, B.P........

With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination

Halibut Liver Oil Capsules.......

Any disease or condition in a pensioner

Hexachlorophane with Entsufon....

Any disease or condition in a patient receiving treatment in or at an approved hospital

Hexachlorophane with Lissapol....

Hexachlorophane in Soap Solution

Hydrocortisone Injection.........

With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection

Hydrocortisone Acetate Injection, B.P.

Intra-articular use

Hydrocortisone Sodium Succinate Injection

Acute adrenal failure due to medical or surgical crises

 

Stevens-Johnson syndrome

Hydrocortisone Sodium Succinate Soluble Tablet

With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report

Hydroxocobalamin Injection, B.P. (100 microgram strength)

Established megalocytic anaemia

Hydroxocobalamin Injection, B.P. (1,000 microgram strength)

Neuroblastoma

 

Sub-acute combined degeneration of the cord

Hydroxyprogesterone Caproate....

Habitual abortion

Imipramine Tablets, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

 

With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital


Fifth Schedulecontinued

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

Imipramine Tablets, B.P.—continued

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride

Indomethacin................

Any disease or condition in a patient receiving treatment in or at an approved hospital

Isoniazid Tablets, B.P...........

Tuberculosis

Kanamycin Sulphate...........

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the only appropriate antibiotic

Kitasamycin.................

Any disease or condition in a patient receiving treatment in or at an approved hospital

Levorphanol Tartrate...........

Obstetrical use

 

Severe intractable pain

Liothyronine Tablets, B.P........

Myxoedema

 

Myxoedema coma

Lipopancreatin...............

Any disease or condition in a patient receiving treatment in or at an approved hospital

Lofenalac

With the written authority of the Director-General, phenylketonuria

Medroxyprogesterone Acetate.....

Endometrial carcinoma

Mercaptopurine Tablets, B.P......

Allergic angiitis

 

Leukaemia

 

Lupus erythematosus

 

Periarteritis

Mestanolone.................

Mammary carcinoma

 

With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis

Methacycline................

A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus

Methandienone Tablets, B.P......

With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis

Methenolone Acetate...........

Methicillin Sodium............

Any disease or condition in a patient receiving treatment in or at an approved hospital

Methicillin Injection, B.P........

Methotrexate Tablets...........

Leukaemia and neoplastic disease

Methotrexate Injections.........

Any disease or condition in a patient receiving treatment in or at an approved hospital

Minafen....................

With the written authority of the Director-General, phenylketonuria

Morphine Sulphate, B.P. with Tacrine Tablets 

Severe intractable pain

Mustine Hydrochloride Injection

Malignant lymphoma and related conditions

Nalidixic Acid

Any disease or condition in a patient receiving treatment in or at an approved hospital


Fifth Schedulecontinued

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

Nandrolone Phenylpropionate Injection, B.P.

With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis

Nandrolone Decanoate..........

Neomycin Sulphate Tablets.......

Bowel sterilization preparatory to major surgery

Nicotinic Acid Tablets, B.P.......

Any disease or condition in a pensioner

Nitrofurantoin Tablets, B.P.......

Urinary tract infections

Nitrofurantoin Oral Suspension....

Nitromin...................

Malignant lymphoma and related conditions

Nystatin...................

Proven monilia infections

Orciprenaline Sulphate Injection...

Any disease or condition in a patient receiving treatment in or at an approved hospital

Orciprenaline Sulphate Solution for Inhalation 

Oxycodone Pectinate...........

Late-stage malignancy

Oxymesterone...............

With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis.

Oxytetracycline Hydrochloride Capsules 

A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus

Oxytetracycline Tablets, B.P......

Oxytetracycline Hydrochloride Injections 

Calcium di-Oxytetracycline Oral Suspension

Calcium di-Oxytetracycline Paediatric Drops

Oxytocin Nasal Spray..........

Induction of labour

Pancreatin, B.P...............

Fibrocystic disease

Pancreatin Enzyme U.S.N.F. XI....

Pancreatico-duodenectomy

 

Pancreatic steatorrhoea

Para-Aminosalicylic Acid........

Tuberculosis

Paracetamol Suspension.........

Any disease or condition in a pensioner.

Paracetamol Tablets, B.P.........

Paramethasone Acetate.........

With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection

Paraffin Liquid Emulsion........

Any disease or condition in a pensioner

Paraffin Liquid Emulsion with Phenolphthalein 

Pargyline Hydrochloride.........

Any disease or condition in a patient receiving treatment in or at an approved hospital

Penicillamine................

With the written authority of the Director-General, Wilson’s disease (hepatolenticular degeneration)

Peritoneal Dialysis Solution......

Any disease or condition in a patient receiving treatment in or at an approved hospital

Pethidine Hydrochloride with Levallorphan Tartrate

Obstetrical use

Benzylpenicillin with Streptomycin Sulphate

Endocarditis due to Streptococcus faecalis or Streptococcus viridans

Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate

Phenacetin with Codeine Phosphate and Pentobarbitone Sodium

Any disease or condition in a pensioner

Phytomenadione Injection, B.P.....

Antidote to anticoagulants

Pituitary, Posterior Lobe, Insufflation 

Diabetes insipidus

Polymyxin B. Sulphate Injection...

Any disease or condition in a patient receiving treatment in or at an approved hospital


Fifth Schedulecontinued

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

Prednisolone Sodium Phosphate Retention Enema

With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report

Prednisolone Tablets, B.P.........

With the written authority of the Director-General—

 

Nodular non-suppurative panniculitis (Christian-Weber disease)

 

A disease or condition specified in this column in relation to Cortisone Injection except total adrenalectomy, Addison’s disease or adrenocortical hypoplasia

Prednisolone Acetate Injection.....

 

Prednisolone Methyl Acetate Injections

 

Prednisolone Tertiary Butyl Acetate Injections

Intra-articular use

Prednisolone Trimethylacetate Injections

 

Methylprednisolone Tablets, B.P....

 

Methylprednisolone Capsules......

With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets

Prednisolone with Magnesium Trisilicate and Dried Aluminium Hydroxide Gel

Prednisolone Sodium Hemisuccinate

With the written authority of the Director-General, medical or surgical crises

Prednisone Tablets, B.P..........

With the written authority of the Director General, a disease or condition specified in this column in relation to Prednisolone Tablets

Prednisone with Magnesium Trisilicate and Dried Aluminium Hydroxide Gel 

Progesterone.................

Habitual abortion

Protoveratrine A..............

Hypertensive crises

Pyrazinamide................

Any disease or condition in a patient receiving treatment in or at an approved hospital

Pyridostigmine Injection, B.P......

Myasthenia gravis

Pyridostigmine Tablets, B.P.......

Pyridoxine Hydrochloride Tablets

Peripheral neuritis due to isoniazid therapy

 

Radiation sickness

Riboflavine Tablets............

Any disease or condition in a pensioner

Senna Fruit Extract (Standardised)

Sobee.....................

With the written authority of the Director-General—

 

Galactosaemia

 

Lactose intolerance

 

Milk allergy in children under the age of four years

Sodium Aminosalicylate Tablets B.P.

Tuberculosis

Sodium Aminosalicylate Injection

Sodium Aminosalicylate Cachets

Sodium Aminosalicylate Granules

Sodium Folate................

Macrocytic anaemia

Sprue or the sprue-like syndrome

Spiramycin..................

A disease or condition specified in this column in relation to Erythromycin

Spironolactone...............

With the written authority of the Director-General, to supplement other diuretics when these have proved inadequate.

Stanolone...................

Mammary carcinoma

 

With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis

Stanozolol..................

With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis


Fifth Schedulecontinued

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

Stilboestrol Injection............

Carcinoma of the prostate

Stilboestrol Tablets, B.P..........

Mammary carcinoma

 

Any disease or condition in a pensioner

Streptomycin Sulphate Injections....

Bacillary dysentery that is resistant to the Sulphonamides

 

Brucellosis

 

Chancroid

 

Endocarditis due to Streptococcus faccalis or Streptococcus viridans

 

Friedlander bacillus infections

 

Haemophilus influenzae infections

 

Plague

 

Pseudomonas pyocyanea infections

 

Rat-bite fever (Streptobacillus moniliformis)

 

Salmonella infections

 

Surgical conditions of the bowel (pre-operative and post-operative)

 

Surgical conditions of the thoracic organs

 

Tuberculosis

 

Tularaemia

 

Urinary tract infections that are resistant to the Sulphonamides

Sulphasalazine................

Ulcerative colitis

Sultiame....................

For use where other anticonvulsants have failed

Surgical Cement...............

Ileostomy or colostomy conditions

Surgical Cement Solvent.........

Sustanon....................

 

Testosterone Implants, B.P........

Castration syndrome (male and female)

Testosterone Oenanthate.........

Klinefelter Reifenstein Albright syndrome

Testosterone Propionate Injection, B.P. 

Mammary carcinoma

Methyltestosterone Tablets, B.P.....

 

Methyltestosterone, B.P..........

 

Tetanus Immune Globulin (Human)

With the written authority of the Director-General, where patients are known to be sensitive to horse serum and cattle serum.

Tetracycline Capsules, B.P........

 

Tetracycline Tablets, B.P.........

 

Tetracycline Injections..........

 

Tetracycline Hydrochloride, with a buffering agent—Capsules and Injection 

A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus

Rolitetracycline...............

Tetracycline Granules...........

Tetracycline Paediatric Drops......

 

Tetracycline Oral Suspension......

 

Tetracycline with a buffering agent—Paediatric Drops 

 

Tetracycline with a buffering agent—Oral Suspension

 

 

Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis

Tetracycline with a buffering agent and Amphotericin B 

A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus

Tetracycline with a buffering agent and Nystatin

 

 


Fifth Schedulecontinued

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

Thiambutosine Tablets, B.P........

Hansen’s disease

 

Any disease or condition in a pensioner

 

Any disease or condition in a patient receiving treatment in or at an approved hospital

 

With the written authority of the Director-General—

 

Late-stage malignancy

 

Radiation sickness

Thioridazine Tablets, B.P.........

With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

Thioridazine.................

 

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride

Thyrotrophin.................

Any disease in or condition in a patient receiving treatment in or at an approved hospital

Tragacanth (Gum Karaya)........

Ileostomy or colostomy conditions

Tretamine...................

Malignant lymphoma and related conditions

Triamcinolone................

With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets

Trifluoperazine Tablets, B.P.......

Any disease or condition in a pensioner

 

Any disease or condition in a patient receiving treatment in or at an approved hospital

 

With the written authority of the Director-General—

 

Late-stage malignancy

 

Radiation sickness

 

With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

 

The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride

Trimetaphan Injection, B.P........

Hypotensive for anaesthesia

Vadrine....................

Any disease or condition in a patient receiving treatment in or at an approved hospital

Vasopressin Nasal Spray.........

Diabetes insipidus

Velactin....................

With the written authority of the Director-General—

 

Galactosaemia

 

Lactose intolerance

 

Milk allergy in children under the age of four years

 


Fifth Schedulecontinued

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

 

Vinblastine Sulphate...........

Hodgkin’s disease

Viomycin Sulphate............

Any disease or condition in a patient receiving treatment in or at an approved hospital

Viomycin Sulphate Injection, B.P.

 

 

Tuberculosis

Viomycin Sulphate with Viomycin Pantothenate

 

Vitamin A with Aneurine Hydro-

 

chloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D

Any disease or condition in a pensioner

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

_________________

By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.